Top compounds associated with response to ZYG11A


Feature Type Standardized
Nominal ANOVA
mRNA neratinib CTRPv2 pan-cancer AAC -0.11 0.006
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.006
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.097 0.007
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.007
mRNA Irinotecan gCSI pan-cancer AAC -0.16 0.007
mRNA Doxorubicin gCSI pan-cancer AAC -0.15 0.008
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.14 0.008
mRNA AS605240 GDSC1000 pan-cancer AAC -0.092 0.008
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.009
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.092 0.01
Download CSV